에 대한 최신 뉴스 Verano Holdings (OTC:VRNOF) 주식

Verano Holdings

Verano Holdings Corp is a vertically integrated multi-state cannabis operator in the United States. The Company has two reportable segments: (i) cultivation (wholesale) and (ii) retail. The company's consumer brands include Encore, Avexia, MUV, Savvy, BITS and Verano. The company's retail dispensaries operate under brands including Zen Leaf and MUV. The company derives its revenues from Retail segment.

VERANO HLDGS CORP by Verano Holdings Corp.

Verano Holdings Corp

<p>Roth Capital  analyst Joe Reagor   maintains MAG Silver (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MAG#AMEX">MAG</a>) with a Neutral and raises the price target from $18 to $21.</p>


News

Price Target

Analyst Ratings

Roth Capital Maintains Neutral on MAG Silver, Raises Price Target to $21

<p>If you've ever wished there was a simple way to enjoy pure, mineral-rich water and freshly brewed coffee without the hassle of refills, plumbing hookups, or endless plastic waste, you're down to your final chance to make it happen. Kara Pod — the world's first self-refilling coffee machine that generates clean drinking water straight from the air — is almost at the finish line of its Kickstarter campaign. Early supporters<a href="https://www.kickstarter.com/projects/karawater/karapod?ref=48p363"> have less than 25 hours left to lock in exclusive savings that won't be offered again</a>, with discounts reaching up to $340 off the expected retail price. Whether you live in a small apartment, an off-grid cabin, or a busy family home, Kara Pod offers a way to drink better without compromise, and time to secure yours is almost up.</p>
<h2 class="wp-block-heading"><strong>What Makes Kara Pod Different?</strong></h2>
<p>At first glance, <a href="https://www.kickstarter.com/projects/karawater/karapod?ref=48p363">Kara Pod</a> looks like a sleek countertop coffee machine. But inside, it's doing something remarkable. Instead of requiring a plumbing connection or water deliveries, Kara Pod draws moisture directly from the surrounding air. Using advanced filtration and purification, it transforms that humidity into fresh, alkaline water you can drink immediately or use to brew coffee. Every drop passes through a multi-stage process that includes dual UV sterilization, a carbon filter, and final mineralization, so you end up with clean, great-tasting water enhanced with calcium, magnesium, and sodium. The internal 3.2-liter tank holds enough for about seven bottles of water or up to eighteen cups of coffee each day, and because everything is automated, you never have to refill a jug or connect a hose — just plug it in and let it get to work.</p>
<h2 class="wp-block-heading"><strong>Coffee and Hydration in One Appliance</strong></h2>
<p>Beyond its water-generating abilities, Kara Pod is also a full-featured coffee maker designed to deliver a barista-quality experience. It's compatible with both Kara's own compostable coffee pods and Nespresso Original Pods, so you can choose your preferred blend or roast. Unlike many all-in-one machines, Kara Pod has separate dispensing nozzles — one dedicated to water, the other to coffee — so there's no crossover of flavors or residues. Through the touchscreen, you can customize cup size, adjust coffee strength, and save your favorite settings. That means you can pour a glass of fresh mineral water and then immediately brew an espresso without swapping tanks or cleaning components in between. It's an unusually thoughtful design for anyone who wants both hydration and high-quality coffee without cluttering the kitchen.</p>
<h2 class="wp-block-heading"><strong>No Refills, No Plumbing, No Plastic Waste</strong></h2>
<p>A big reason so many people have backed Kara Pod is how effortless it is to operate. There's no need for bottled water, no expensive delivery contracts, and no refilling a reservoir every day. Kara Pod simply creates water as you need it, drawing from the air in your kitchen or workspace. Because it runs on standard power outlets — either 110V or 220V — it works almost anywhere. This design doesn't just save you time; it also significantly reduces your environmental footprint. You won't be throwing away single-use plastic bottles, hauling delivery jugs, or creating unnecessary waste. Even the coffee pods are compostable.</p>
<h2 class="wp-block-heading"><strong>Technical Details at a Glance</strong></h2>
<p>While Kara Pod is compact, it's packed with capability. The machine measures roughly 15 inches by 9 inches by 14 inches — comparable in size to a Keurig K-Select — and weighs about 13 pounds. It has a storage capacity of 3.2 liters, enough for daily use by singles, couples, or small families. The power consumption is 270 watts, and the voltage range is fully compatible with both US and international outlets. All controls are handled through an intuitive touchscreen that walks you through setup, customization, and maintenance reminders.</p>
<h2 class="wp-block-heading"><strong>Who Is Kara Pod Designed For?</strong></h2>
<p>Kara Pod is an easy fit for a wide range of people and spaces. If you live in an apartment where tap water is unreliable or tastes unpleasant, Kara Pod gives you a consistent source of mineral-rich water without plumbing. For off-grid living, RV trips, or cabins where running water isn't practical, it offers a self-sufficient hydration solution. Families looking to cut back on plastic waste will appreciate how it replaces bottled water entirely, while small offices and workspaces can use it to provide healthier, hassle-free drinks throughout the day. Essentially, anyone who wants clean water and quality coffee, anywhere, will find Kara Pod surprisingly versatile.</p>
<h2 class="wp-block-heading"><strong>Kickstarter Pricing and Rewards</strong></h2>
<p>During this final stretch of the campaign, backers can still claim significant savings. A <a href="https://www.kickstarter.com/projects/karawater/karapod?ref=48p363">single Kara Pod is available starting from $459</a>, which represents up to $340 off the estimated retail price. There are also bundled options — like a single unit plus extra filter sets for longer-term use, starting around $477, or multi-unit packages ideal for gifting or outfitting multiple rooms. Shipping costs will be calculated after the campaign wraps up, and you can view estimated rates directly on the Kickstarter page. Given how quickly the campaign is closing, many reward tiers are almost sold out.</p>
<h2 class="wp-block-heading"><strong>Why Back Kara Pod Before Time Runs Out?</strong></h2>
<p>Backing Kara Pod now isn't just about getting the best price. Early backers play a pivotal role in making this new category of appliance widely available. The project is structured as all-or-nothing — if it doesn't hit the funding goal by Wednesday, July 2, 2025, at 6:45 AM (Pacific), production won't proceed and your card won't be charged. Already, hundreds of backers have pledged support and shared feedback, with a lively comment section and transparent updates from the creators. If you've been considering it, this is the moment to act.</p>
<h2 class="wp-block-heading"><strong>How to Reserve Your Kara Pod</strong></h2>
<p>There are only hours left to secure your Kara Pod and start transforming how you drink water and coffee every day. Backing is simple: just visit the Kickstarter page, choose your reward, and complete your pledge before the campaign closes. After that, these early-backer discounts will disappear, and you'll have to wait for retail availability at full price. Invest now with as little a $1, or <a href="https://www.kickstarter.com/projects/karawater/karapod?ref=48p363"><strong>invest $459 to get a Kara Pod</strong></a> (at a discount of 43% off its retail price). No refills. No plumbing. No plastic. Just a better way to stay hydrated—and you have less than 25 hours to claim it.</p>


Tech

Only 25 Hours Left: Back Kara Pod and Invest Early in the Future of Air-to-Water Tech

<p>Roth Capital  analyst Joe Reagor   reiterates Coeur Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) with a Buy and raises the price target from $10 to $12.</p>


Reiteration

Roth Capital Reiterates Buy on Coeur Mining, Raises Price Target to $12

<p><strong>Jumia Technologies AG &#8211; ADR</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NYSE">JMIA</a>) shares are trading higher Tuesday afternoon as the company becomes the subject of takeover interest from <strong>Axian Telecom</strong>, per a <strong>Bloomberg</strong> <a href="https://www.bloomberg.com/news/articles/2025-07-01/e-commerce-firm-jumia-said-to-draw-takeover-interest-from-axian">report</a>.</p>
<p><strong>What To Know:</strong> Axian Telecom recently raised $600 million in financing, according to sources who spoke with Bloomberg. These funds are intended to refinance existing debt and strategically position the company for a possible acquisition of Jumia. Deliberations are <a href="https://www.bloomberg.com/news/articles/2025-07-01/e-commerce-firm-jumia-said-to-draw-takeover-interest-from-axian">reportedly</a> ongoing and private, with no definitive agreement reached, per Bloomberg.</p>
<p>This potential merger follows Axian&#8217;s disclosure in May of an 8% stake in Jumia. Such an acquisition could create a powerful synergy, combining Axian&#8217;s telecommunications infrastructure with Jumia&#8217;s established e-commerce network. Representatives for both Jumia and Axian have declined to comment to Bloomberg on the speculation.</p>
<p><strong>What Else:</strong> Jumia is a leading <a href="https://www.benzinga.com/topic/e-commerce">e-commerce</a> platform in Africa, often called the &#8220;Amazon of Africa.&#8221; It provides a marketplace for consumers to buy a wide range of products, a logistics service for delivery and a payment platform, JumiaPay.</p>
<p>News of a potential takeover by Axian Telecom would likely cause Jumia&#8217;s stock to rise for a key reason: acquisition premium. Typically, a company seeking to acquire another offers to buy its shares at a price higher than the current market value. </p>
<p>The prospect of this higher payout makes the stock more attractive, driving up its price as investors anticipate the potential acquisition.</p>
<p><strong>Price Action:</strong> According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, JMIA shares are trading higher by 16.5% to $4.67. JMIA has a 52-week high of $15.04 and a 52-week low of $1.60.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/pressreleases/25/06/ac46181754/jumia-opens-new-warehouse-in-egypt-to-boost-logistics-job-creation-and-digital-economy">Jumia Opens New Warehouse in Egypt to Boost Logistics, Job Creation, and Digital Economy</a></strong></p>
<h2 class="wp-block-heading">How To Buy JMIA Stock</h2>
<p>Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. </p>
<p>For example, in Jumia Technologies&#8217; case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p>


JMIA

Jumia (JMIA) Stock Surges On Axian Takeover Buzz: What Investors Need To Know

<p>Roth Capital  analyst Joe Reagor   maintains Anglogold Ashanti (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>) with a Buy and raises the price target from $52 to $54.</p>


Roth Capital Maintains Buy on Anglogold Ashanti, Raises Price Target to $54

<p>Roth Capital  analyst Joe Reagor   downgrades Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) from Buy to Neutral and raises the price target from $2.75 to $3.5.</p>


Downgrades

Roth Capital Downgrades Avino Silver & Gold Mines to Neutral, Raises Price Target to $3.5

<p><i>Leader in vessel monitoring and control solutions joins Teledyne's Raymarine brand</i></p>
<p>Teledyne Technologies Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) ("Teledyne") announced today the acquisition of assets of Maretron, including the brand's Octoplex, MPower and MConnect product lines from Littelfuse, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFUS#NASDAQ">LFUS</a>). The purchase will allow Teledyne's Raymarine business to deliver deeper integration and automation for boat builders as a one-stop-shop, greatly expand product functionality for consumers, and create new and exciting business opportunities for Raymarine and its partners. Raymarine intends to maintain Maretron's trade name and product lines to ensure a seamless transition for existing Maretron customers.</p>


LFUS

Teledyne Technologies Acquires Assets Of Maretron, Including Brand's Octoplex, MPower And MConnect Product Lines From Littelfuse; Terms Undisclosed

<h3>Gainers</h3>
<ul>
<li><strong>Studio City Intl Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSC#NYSE">MSC</a>) shares moved upwards by 31.6% to $4.18 during Tuesday's regular session. The market value of their outstanding shares is at $611.4 million. </li>
<li><strong>Tilly's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) shares rose 20.28% to $1.66. The company's market cap stands at $41.6 million. </li>
<li><strong>Jumia Technologies</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NYSE">JMIA</a>) stock increased by 16.04% to $4.67. The market value of their outstanding shares is at $492.3 million. </li>
<li><strong>Sonder Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOND#NASDAQ">SOND</a>) stock rose 14.37% to $3.09. The company's market cap stands at $29.7 million. </li>
<li><strong>Bloomin Brands</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) stock rose 14.22% to $9.84. The market value of their outstanding shares is at $732.3 million. </li>
<li><strong>Designer Brands</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBI#NYSE">DBI</a>) stock rose 13.65% to $2.71. The market value of their outstanding shares is at $116.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Wag Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) stock fell 29.1% to $0.16 during Tuesday's regular session. The company's market cap stands at $11.7 million. </li>
<li><strong>Mullen Automotive</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares declined by 23.15% to $0.33. </li>
<li><strong>Flanigan'S Enterprises</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BDL#AMEX">BDL</a>) shares declined by 16.48% to $29.0. The company's market cap stands at $64.5 million. </li>
<li><strong>Dogness (Intl)</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) shares fell 16.22% to $13.74. The company's market cap stands at $233.3 million. </li>
<li><strong>Lulus Fashion Lounge</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) shares decreased by 15.34% to $0.25. The market value of their outstanding shares is at $12.4 million. </li>
<li><strong>Lixiang Education Hldg</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) shares decreased by 12.85% to $1.22. The company's market cap stands at $1.6 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Movers

BLMN

DOGZ

LVLU

LXEH

MULN

SOND

TLYS

12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li><strong>Neurogene</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGNE#NASDAQ">NGNE</a>) shares increased by 32.3% to $19.77 during Tuesday's regular session. The market value of their outstanding shares is at $213.2 million. </li>
<li><strong>Adial Pharmaceuticals</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) stock increased by 32.16% to $0.4. The company's market cap stands at $4.7 million. </li>
<li><strong>Lixte Biotechnology</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) shares moved upwards by 27.66% to $1.16. The market value of their outstanding shares is at $2.4 million. </li>
<li><strong>Vivos Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) shares increased by 25.47% to $3.96. The company's market cap stands at $18.6 million. </li>
<li><strong>Soligenix</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock increased by 18.32% to $1.55. The market value of their outstanding shares is at $4.2 million. </li>
<li><strong>Mustang Bio</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares moved upwards by 18.22% to $1.13. The company's market cap stands at $4.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Oragenics</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) stock fell 57.3% to $1.63 during Tuesday's regular session. The company's market cap stands at $2.7 million. </li>
<li><strong>Geovax Labs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) shares decreased by 46.0% to $0.47. The market value of their outstanding shares is at $13.7 million. </li>
<li><strong>Cellectar Biosciences</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) stock fell 31.23% to $4.89. The market value of their outstanding shares is at $12.8 million. </li>
<li><strong>Artelo Biosciences</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>) stock decreased by 28.33% to $9.51. The company's market cap stands at $7.2 million. </li>
<li><strong>Exicure</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares decreased by 14.64% to $6.01. The market value of their outstanding shares is at $44.4 million. The company's, Q1 earnings came out 2 days ago. </li>
<li><strong>Enhabit</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHAB#NYSE">EHAB</a>) shares fell 14.16% to $8.28. The company's market cap stands at $488.1 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ADIL

ARTL

CLRB

EHAB

GOVX

LIXT

MBIO

NGNE

OGEN

SNGX

VVOS

XCUR

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li><strong>BioNexus Gene Lab</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) stock moved upwards by 230.9% to $10.16 during Tuesday's regular session. The company's market cap stands at $5.5 million. </li>
<li><strong>Shoals Technologies Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) shares moved upwards by 19.76% to $5.09. The market value of their outstanding shares is at $710.4 million. </li>
<li><strong>WF International</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) stock rose 18.14% to $3.19. The company's market cap stands at $18.6 million. </li>
<li><strong>Shimmick</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHIM#NASDAQ">SHIM</a>) stock increased by 16.37% to $1.99. The market value of their outstanding shares is at $58.8 million. </li>
<li><strong>FiscalNote Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) shares increased by 15.3% to $0.62. The company's market cap stands at $84.8 million. </li>
<li><strong>BGSF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGSF#NYSE">BGSF</a>) shares moved upwards by 12.27% to $7.15. The company's market cap stands at $70.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Globavend Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) stock fell 39.4% to $0.07 during Tuesday's regular session. The market value of their outstanding shares is at $1.7 million. </li>
<li><strong>374Water</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) stock decreased by 26.96% to $0.24. The market value of their outstanding shares is at $46.9 million. </li>
<li><strong>Capstone Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPS#NASDAQ">CAPS</a>) stock declined by 18.89% to $1.46. The company's market cap stands at $9.3 million. </li>
<li><strong>Professional Diversity</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) stock fell 17.16% to $2.8. The company's market cap stands at $7.0 million. </li>
<li><strong>Arrive AI</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAI#NASDAQ">ARAI</a>) stock decreased by 11.69% to $10.31. The company's market cap stands at $385.3 million. </li>
<li><strong>OceanPal</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) stock fell 11.42% to $1.63. The company's market cap stands at $13.8 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ARAI

BGLC

BGSF

CAPS

IPDN

NOTE

SCWO

SHIM

SHLS

12 Industrials Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li><strong>Wolfspeed</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares increased by 125.7% to $0.9 during Tuesday's regular session. The company's market cap stands at $62.0 million. </li>
<li><strong>BitMine Immersion Techs</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) stock increased by 89.67% to $64.3. The market value of their outstanding shares is at $205.5 million. </li>
<li><strong>Argo Blockchain</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) shares moved upwards by 83.1% to $0.34. The market value of their outstanding shares is at $11.8 million. </li>
<li><strong>ClearOne</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) stock moved upwards by 74.6% to $10.04. The market value of their outstanding shares is at $9.9 million. </li>
<li><strong>Saiheat</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIH#NASDAQ">SAIH</a>) shares moved upwards by 20.02% to $8.57. The market value of their outstanding shares is at $12.1 million. </li>
<li><strong>Soluna Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNHP#NASDAQ">SLNHP</a>) shares rose 16.27% to $3.0. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Youxin Technology</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YAAS#NASDAQ">YAAS</a>) stock declined by 86.8% to $0.55 during Tuesday's regular session. The company's market cap stands at $139.9 million. </li>
<li><strong>Sonim Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) shares decreased by 48.07% to $0.63. The company's market cap stands at $12.6 million. </li>
<li><strong>Aeva Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NASDAQ">AEVA</a>) stock decreased by 24.01% to $28.72. The market value of their outstanding shares is at $2.0 billion. </li>
<li><strong>Ostin Technology Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock declined by 16.93% to $0.13. The company's market cap stands at $17.0 million. </li>
<li><strong>Auddia</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock decreased by 15.15% to $4.79. The company's market cap stands at $3.5 million. </li>
<li><strong>Saverone 2014</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock fell 14.35% to $2.54. The market value of their outstanding shares is at $1.3 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AEVA

ARBK

AUUD

BMNR

CLRO

SAIH

SLNHP

SONM

SVRE

WOLF

YAAS

12 Information Technology Stocks Moving In Tuesday's Intraday Session

<p>Roth Capital  analyst Joe Reagor   downgrades Hecla Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) from Buy to Neutral and maintains the price target from $6 to $6.</p>


Roth Capital Downgrades Hecla Mining to Neutral, Maintains Price Target to $6

<p><i>New PG&amp;E Program Provides Matching Bill Credits of up to $1,000 for Eligible Customers</i></p>
<p>OAKLAND, Calif., July 1, 2025 /PRNewswire/ -- Pacific Gas and Electric Company (PG&amp;E) is committing $50 million to new and existing financial assistance programs to support eligible customers with paying past-due energy bills. These programs include PG&amp;E's new Match My Payment Program and the existing PG&amp;E Relief for Energy Assistance through Community Help (REACH) program.</p>


PG&E Commits $50M To New And Existing Financial Assistance Programs To Support Eligible Customers With Paying Past-Due Energy Bills

<p>Roth Capital  analyst Philip Shen   initiates coverage on MasTec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>) with a Buy rating and announces Price Target of $210.</p>


Initiation

Roth Capital Initiates Coverage On MasTec with Buy Rating, Announces Price Target of $210

<p>More retirees are staying busy — but not everyone is working. Many retirees choose to stay connected to work, even if only part-time. Whether it's substitute teaching, freelancing, or picking up a fun side gig, plenty of retirees say they enjoy having a reason to get out of the house and some extra income to go with it.</p>
<p>But that's not the whole story. In fact, a large group of retirees have stepped away from paid work entirely — and say they have no intention of returning.</p>
<p>"I will never work again," one Reddit user wrote on the forum <a href="https://www.reddit.com/r/retirement/comments/1lj7oxq/id_like_to_hear_from_those_of_you_who_do_not_work/">r/Retirement</a>, launching a conversation that's gained momentum among those who identify as fully retired. These retirees aren't picking up side hustles or consulting jobs. They're done — and content to be.</p>
<p><strong>Don't Miss:</strong></p>
<ul class="wp-block-list">
<li><strong>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning"><strong>Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</strong></a>.</strong></li>
<li><strong>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment"><strong>Back a bold new approach to cancer treatment with high-growth potential.</strong></a></strong></li>
</ul>
<h2 class="wp-block-heading">Why Some Retirees Are Fully Stepping Away</h2>
<p>Among current retirees, 71% say they are not working in any capacity, according to a <a href="https://www.cnbc.com/2024/09/06/survey-how-many-americans-plan-to-work-in-retirement.html">CNBC survey</a>. While some continue working by choice or necessity, a quiet but firm group is opting out completely.</p>
<p>For some, health plays a major role. One Redditor shared that a car accident 16 months into retirement left them unable to work — but also gave them clarity. Now, their days are focused on healing, enjoying time with their spouse, and planning small trips. "That's good enough for me," they wrote.</p>
<p>Others say they've simply done their time. After decades of <a href="https://www.benzinga.com/personal-finance/entrepreneurship/25/06/46074452/juggling-multiple-high-paying-jobs-seemed-like-a-dream-until-the-guilt-kicked-in-it-felt-bad-to-constantly-lie-to-my-coworkers">high-stress work</a>, some retirees relish doing nothing at all — and don't feel the need to explain it.</p>
<p>"I'm the person everyone says you shouldn't be," one 71-year-old wrote. "Don't ‘do' much if anything — except what I like." That includes quiet mornings, staying up all night, and ignoring most scheduled social activities.</p>
<p><strong>Trending: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor"><strong>Now Raising at $3/Share</strong></a></strong></p>
<h2 class="wp-block-heading">Retirement, Without A Side Hustle, Can Still Be Rich With Meaning</h2>
<p>Contrary to the idea that work gives life purpose, many retirees say they find joy and fulfillment in everyday routines. One described <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/06/46132531/suze-orman-warns-most-peoples-retirement-wont-be-gradual-here-are-3-curveballs-to-prepare-for">retirement</a> as "like being a kid again — except I have a car and money."</p>
<p>Another shared how retirement gave him the chance to return to who he once was: "If my 16-year-old self showed up at the door to judge my life, I'd want him to feel like he finally got let off the leash."</p>
<p>Many are keeping active in other ways — just not for pay. Some garden, race cars, read, or pursue hobbies. Others spend time with grandchildren or simply relax.</p>
<p><strong><em>See Also: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air"><strong><em>And You Can Invest At Just $6.37/Share</em></strong></a></em></strong></p>
<h2 class="wp-block-heading">Why The Next Generation May Take A Different Path</h2>
<p>While many current retirees have stopped working completely, younger adults may be more likely to stay engaged with <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/06/46131760/i-thought-i-could-still-work-a-little-retiree-hit-with-surprise-9648-social-security-overpayment-notice">work after retirement</a>. Just 11% of future retirees say they plan to stop working entirely, according to the CNBC survey.</p>
<p>For those unsure if they'll be ready to fully retire, continuing to work can offer both financial and emotional benefits. Experts say even part-time income can stretch retirement savings and boost Social Security payouts.</p>
<p>But for those who can afford to stop working — and want to — the stories from fully retired Redditors offer an encouraging message: life after work doesn't have to be busy to be meaningful.</p>
<p><strong>Read Next: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv"><strong>The percentage may shock you</strong></a>.</strong></p>
<p><em><strong>Image: Shutterstock</strong></em></p>


Personal Finance

'I Will Never Work Again': What Retirees Who Gave Up Work Completely Say About Life Now

Trading Ideas

AMZN

CNBC Halftime Report Final Trades: Amazon, Citigroup, Chipotle Mexican Grill

<p>Financial giants have made a conspicuous bullish move on NextEra Energy. Our analysis of options history for NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) revealed 13 unusual trades.</p>
<p>Delving into the details, we found 46% of traders were bullish, while 46% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $334,028, and 7 were calls, valued at $372,138.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $65.0 and $77.5 for NextEra Energy, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in NextEra Energy's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to NextEra Energy's substantial trades, within a strike price spectrum from $65.0 to $77.5 over the preceding 30 days.</p>
<h3>NextEra Energy Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751389270_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$1.3</td>
<td>$1.21</td>
<td>$1.21</td>
<td>$69.00</td>
<td>$96.5K</td>
<td>100</td>
<td>2.0K</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$1.29</td>
<td>$1.18</td>
<td>$1.18</td>
<td>$69.00</td>
<td>$80.3K</td>
<td>100</td>
<td>681</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$8.7</td>
<td>$8.55</td>
<td>$8.55</td>
<td>$65.00</td>
<td>$77.8K</td>
<td>169</td>
<td>188</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/25/25</td>
<td>$3.55</td>
<td>$3.4</td>
<td>$3.4</td>
<td>$70.00</td>
<td>$68.0K</td>
<td>248</td>
<td>625</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$0.49</td>
<td>$0.48</td>
<td>$0.49</td>
<td>$72.00</td>
<td>$59.0K</td>
<td>2.1K</td>
<td>1.6K</td>
</tr>
</tbody>
</table>
</p>
<h3>About NextEra Energy</h3>
<p>NextEra Energy's regulated utility, Florida Power &amp; Light, is the largest rate-regulated utility in Florida. The utility distributes power to over 6 million customer accounts in Florida and owns 36 gigawatts of generation. FP&amp;L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with more than 37 GW of generation capacity, including natural gas, nuclear, wind, and solar.</p>
<p>Having examined the options trading patterns of NextEra Energy, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is NextEra Energy Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 12,485,071, the NEE's price is up by 2.89%, now at $71.42. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 22 days.</li>
</ul>
<h3>Professional Analyst Ratings for NextEra Energy</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $94.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on NextEra Energy, which currently sits at a price target of $94. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for NextEra Energy, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

This Is What Whales Are Betting On NextEra Energy

<p>Benzinga's options scanner just detected over 8 options trades for <strong>CRISPR Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) summing a total amount of $259,313.</p>
<p>At the same time, our algo caught 2 for a total amount of 75,415.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $42.5 and $55.0 for CRISPR Therapeutics, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of CRISPR Therapeutics stands at 576.75, with a total volume reaching 5,779.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in CRISPR Therapeutics, situated within the strike price corridor from $42.5 to $55.0, throughout the last 30 days.</p>
<h3>CRISPR Therapeutics 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751389265_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CRSP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$2.0</td>
<td>$1.7</td>
<td>$1.7</td>
<td>$42.50</td>
<td>$47.4K</td>
<td align="right">19</td>
<td>279</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$1.9</td>
<td>$1.7</td>
<td>$1.9</td>
<td>$55.00</td>
<td>$46.1K</td>
<td align="right">797</td>
<td>1.6K</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$1.7</td>
<td>$1.6</td>
<td>$1.7</td>
<td>$55.00</td>
<td>$40.4K</td>
<td align="right">797</td>
<td>1.4K</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$1.55</td>
<td>$1.35</td>
<td>$1.54</td>
<td>$55.00</td>
<td>$38.7K</td>
<td align="right">797</td>
<td>942</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$6.0</td>
<td>$5.8</td>
<td>$6.0</td>
<td>$42.50</td>
<td>$30.0K</td>
<td align="right">748</td>
<td>50</td>
</tr>
</tbody>
</table>
</p>
<h3>About CRISPR Therapeutics</h3>
<p>Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.</p>
<p>After a thorough review of the options trading surrounding CRISPR Therapeutics, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Current Position of CRISPR Therapeutics</h3>
<ul>
<li>With a trading volume of 1,593,796, the price of CRSP is up by 0.78%, reaching $49.02.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 34 days from now.</li>
</ul>
<h3>Expert Opinions on CRISPR Therapeutics</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $76.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Chardan Capital continues to hold a Buy rating for CRISPR Therapeutics, targeting a price of $82.<br />
&#x2A; In a cautious move, an analyst from HC Wainwright &amp; Co. downgraded its rating to Buy, setting a price target of $65.<br />
&#x2A; An analyst from Clear Street downgraded its action to Hold with a price target of $45.<br />
&#x2A; In a cautious move, an analyst from Piper Sandler downgraded its rating to Overweight, setting a price target of $105.<br />
&#x2A; An analyst from JMP Securities has revised its rating downward to Market Outperform, adjusting the price target to $86. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for CRISPR Therapeutics, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


CRSP

CRISPR Therapeutics Unusual Options Activity

<p>High-rolling investors have positioned themselves bullish on Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in C often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 28 options trades for Citigroup. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 64% bullish and 17% bearish. Among all the options we identified, there was one put, amounting to $33,375, and 27 calls, totaling $2,532,311.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $95.0 for Citigroup over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Citigroup options trades today is 6722.65 with a total volume of 25,284.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Citigroup's big money trades within a strike price range of $30.0 to $95.0 over the last 30 days.</p>
<h3>Citigroup Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751389259_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/17/26</td>
<td>$8.15</td>
<td>$8.0</td>
<td>$8.0</td>
<td>$90.00</td>
<td>$470.3K</td>
<td>1.9K</td>
<td>651</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$6.05</td>
<td>$6.0</td>
<td>$6.0</td>
<td>$82.50</td>
<td>$300.0K</td>
<td>13.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$6.05</td>
<td>$6.0</td>
<td>$6.0</td>
<td>$82.50</td>
<td>$298.8K</td>
<td>13.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$55.55</td>
<td>$55.2</td>
<td>$55.38</td>
<td>$30.00</td>
<td>$199.3K</td>
<td>350</td>
<td>36</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/25/25</td>
<td>$0.76</td>
<td>$0.73</td>
<td>$0.75</td>
<td>$91.00</td>
<td>$187.5K</td>
<td>273</td>
<td>2.5K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Citigroup</h3>
<p>Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.</p>
<p>Following our analysis of the options activities associated with Citigroup, we pivot to a closer look at the company's own performance.</p>
<h3>Citigroup's Current Market Status</h3>
<ul>
<li>With a trading volume of 5,343,125, the price of C is up by 0.56%, reaching $85.59.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 14 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Citigroup</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $93.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Citigroup with a target price of $100.<br />
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on Citigroup with a target price of $94.<br />
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on Citigroup, maintaining a target price of $85. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Citigroup, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


This Is What Whales Are Betting On Citigroup

<p>UniFirst (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-07-02. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that UniFirst will report an <strong>earnings per share</strong> (EPS) of $2.07.</p>
<p>The announcement from UniFirst is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company beat EPS by $0.08, which was followed by a 2.82% drop in the share price the next day.</p>

<p><img src="https://www.benzinga.com/files/images/story/2025/1751389229_0.png" alt="eps graph" /></p>
<h3>Analyst Observations about UniFirst</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on UniFirst.</p>
<p>Analysts have provided UniFirst with 3 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $181.67, suggesting a potential 3.48% downside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Driven Brands Hldgs, ACV Auctions and VSE, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Driven Brands Hldgs, with an average 1-year price target of $22.0, suggesting a potential 88.31% downside.</li>
<li>Analysts currently favor an Buy trajectory for ACV Auctions, with an average 1-year price target of $21.5, suggesting a potential 88.58% downside.</li>
<li>Analysts currently favor an Buy trajectory for VSE, with an average 1-year price target of $142.5, suggesting a potential 24.29% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for Driven Brands Hldgs, ACV Auctions and VSE are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>UniFirst</td>
<td>Neutral</td>
<td>1.95%</td>
<td>$208.07M</td>
<td>1.14%</td>
</tr>
<tr>
<td>Driven Brands Hldgs</td>
<td>Buy</td>
<td>7.09%</td>
<td>$297.82M</td>
<td>0.88%</td>
</tr>
<tr>
<td>ACV Auctions</td>
<td>Buy</td>
<td>25.40%</td>
<td>$99.32M</td>
<td>-3.37%</td>
</tr>
<tr>
<td>VSE</td>
<td>Buy</td>
<td>57.68%</td>
<td>$26.82M</td>
<td>-0.91%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>UniFirst ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. UniFirst is at the top for Return on Equity.</p>
<h3>About UniFirst</h3>
<p>UniFirst Corp provides workplace uniforms, protective clothing, and other workplace products and services to businesses in the United States, Canada, and Europe. The U.S. and Canadian Rental and Cleaning segment that accounts for the majority of the company engages in sales rents and sells clothing and non-garment items, and offers a cleaning service that delivers clean uniforms when it picks up dirty or contaminated ones. Manufacturing segment designs and manufactures uniforms and non-garment items. Specialty garments rental and cleaning segment provides specialty garments, non-garments, and cleaning services for nuclear and classroom applications. The First Aid segment provides safety supplies and pill packaging. The Corporate segment consists of various associated costs.</p>
<h3>UniFirst: Financial Performance Dissected</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> UniFirst's remarkable performance in 3 months is evident. As of 28 February, 2025, the company achieved an impressive revenue growth rate of <strong>1.95%</strong>. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> UniFirst's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>4.06%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> UniFirst's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>1.14%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> UniFirst's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.9%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> UniFirst's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.03</strong>.</p>
<p><a href="https://www.benzinga.com/quote/UNF/earnings"><strong>To track all earnings releases for UniFirst visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

A Look Ahead: UniFirst's Earnings Forecast

Financing

Press Releases

Rainbow Realty Group Completes $12 Million Senior Real Estate Mortgage Loan to Verano Holdings Corp

Verano Expands Connecticut Footprint with Opening of Zen Leaf Ashford, Company's Sixth Retail Location and Closest Cannabis Dispensary1 to University of Connecticut

Verano to Report First Quarter 2025 Financial Results on May 8, 2025

Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer

Verano Elevates Florida Retail Footprint to 81 Dispensaries with the Opening of MÜV New Smyrna Beach

Verano Announces First Quarter 2025 Financial Results

Verano to Celebrate Grand Opening of Zen Leaf Enfield, Company's Seventh Connecticut Dispensary, Throughout Memorial Day Weekend

Verano Announces Exclusive Partnership with Award-Winning Arizona Cannabis Operator Grow Sciences to Bring its Best-In-Class Products to Illinois

Verano Unveils Bodega-Style Dispensary Experience at Zen Leaf Cave Creek in Phoenix

Comments

Verano Holdings

뉴스

에 대한 최신 뉴스 Verano Holdings (OTC:VRNOF) 주식

뉴스

파트너 / 기고자

벤징가 글로벌